Código QR (código de barras bidimensional)

Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study.

OBJECTIVE--To compare the efficacy, tolerance and safety of 50-150 micrograms orally administered iloprost given twice a day versus placebo in patients with Raynaud's syndrome. METHODS--The study was multicentre (n = 3), double blind and placebo controlled. Sixty three patients who had eight or more...

Fuld beskrivelse

Na minha lista:
Udgivet i:Ann Rheum Dis
Principais autores: Belch, J J, Capell, H A, Cooke, E D, Kirby, J D, Lau, C S, Madhok, R, Murphy, E, Steinberg, M
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 1995
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1005556/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7538285/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.54.3.197
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker